PharmaShots | Incisive News in 3 Shots

Subscribe Now

luye pharma

Luye Pharma Launches Erzofri in the US for Schizophrenia and Schizoaffective Disorder

Luye Pharma Launches Erzofri in the US for Schizophrenia and Schizoaffective Disorder

April 7, 2025

Luye Pharma's Rykindo (risperidone) Receives the US FDA’s Approval for the Treatment of Schizophrenia and Bipolar 1 Disorder

Luye Pharma's Rykindo (risperidone) Receives the US FDA’s Approval for the Treatment of Schizophrenia and Bipolar 1 Disorder

January 16, 2023

Luye Pharma Receives NMPA’s Approval of World First Boyoubei (biosimilar, denosumab) to Treat Postmenopausal Women with Osteoporosis

Luye Pharma Receives NMPA’s Approval of World First Boyoubei (biosimilar, denosumab) to Treat Postmenopausal Women with Osteoporos...

November 10, 2022

PharmaShots Weekly Snapshot (December 23-27, 2019)

PharmaShots Weekly Snapshot (December 23-27, 2019)

December 30, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us